Video


Across countries, organizations, and medical societies – guidance on using Prostate Specific Antigen (PSA) testing for screening of prostate cancer has been challenging to navigate. Guidelines may offer conflicting directions and specialist practice in your region may differ from provider to provider. How do we make sense of the evolving landscape and provide safe, patient-centered…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Watching the Video can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in





This content is certified for MainPro+ Credits, log in to access

đź”’ Complete Activity


Speaker(s):

  • Dr Anmol Lamba

Please refer to the video for the speakers’ conflicts of interest